SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Lars Krogvold, Anna Wiberg, Bjørn Edwin, Trond Buanes, Frode Lars Jahnsen, Kristian F. Hanssen, Erik Larsson, Olle Korsgren, Oskar Skog, Knut Dahl-Jørgensen, Insulitis and characterisation of infiltrating T cells in surgical pancreatic tail resections from patients at onset of type 1 diabetes, Diabetologia, 2016, 59, 3, 492

    CrossRef

  2. 2
    Johnny Ludvigsson, Therapies to Preserve β-Cell Function in Type 1 Diabetes, Drugs, 2016, 76, 2, 169

    CrossRef

  3. 3
    Ahmed J. Delli, Åke Lernmark, Endocrinology: Adult and Pediatric, 2016,

    CrossRef

  4. 4
    Sandra Lord, Carla J. Greenbaum, Disease modifying therapies in type 1 diabetes: Where have we been, and where are we going?, Pharmacological Research, 2015, 98, 3

    CrossRef

  5. 5
    Nadir Askenasy, Less Is More: The Detrimental Consequences of Immunosuppressive Therapy in the Treatment of Type-1 Diabetes, International Reviews of Immunology, 2015, 34, 6, 523

    CrossRef

  6. 6
    Shyam Sundhar Bale, Gavrielle Price, Monica Casali, Nima Saeidi, Abhinav Bhushan, Martin L. Yarmush, A highly sensitive microsphere-based assay for early detection of Type I diabetes, TECHNOLOGY, 2014, 02, 03, 200

    CrossRef

  7. 7
    Li Zhang, Pilar Londono, Liping Yu, Stephen Grimes, Peter Blackburn, Peter Gottlieb, George S. Eisenbarth, MAS-1 adjuvant immunotherapy generates robust Th2 type and regulatory immune responses providing long-term protection from diabetes in late-stage pre-diabetic NOD mice, Autoimmunity, 2014, 47, 5, 341

    CrossRef

  8. 8
    Barbara Brooks-Worrell, Jerry P. Palmer, Prevention versus intervention of type 1 diabetes, Clinical Immunology, 2013, 149, 3, 332

    CrossRef

  9. 9
    M. Herrath, M. Peakman, B. Roep, Progress in immune-based therapies for type 1 diabetes, Clinical & Experimental Immunology, 2013, 172, 2
  10. 10
    T. P. Staeva, L. Chatenoud, R. Insel, M. A. Atkinson, Recent Lessons Learned From Prevention and Recent-Onset Type 1 Diabetes Immunotherapy Trials, Diabetes, 2013, 62, 1, 9

    CrossRef

  11. 11
    Oskar Skog, Stella Korsgren, Åsa Melhus, Olle Korsgren, Revisiting the notion of type 1 diabetes being a T-cell-mediated autoimmune disease, Current Opinion in Endocrinology & Diabetes and Obesity, 2013, 20, 2, 118

    CrossRef

  12. 12
    Katerina Stechova, Zbynek Halbhuber, Miluse Hubackova, Jana Kayserova, Lenka Petruzelkova, Jana Vcelakova, Stanislava Kolouskova, Tereza Ulmannova, Maria Faresjö, Ales Neuwirth, Radek Spisek, Anna Sediva, Dominik Filipp, Zdenek Sumnik, Case report: type 1 diabetes in monozygotic quadruplets, European Journal of Human Genetics, 2012, 20, 4, 457

    CrossRef

  13. 13
    G. Mills-Joncour, C. Thivolet, Dépistage et prévention du diabète de type 1, Médecine des Maladies Métaboliques, 2012, 6, 5, 383

    CrossRef

  14. 14
    Diana Moreira, Isabel Pinto Pais, Sandra Rebimbas, Luciana Barbosa, Lúcia Rodrigues, Cristina Costa, Rosa Arménia Campos, Diabetes Mellitus tipo 1 e hepatite autoimune como forma de apresentação precoce da síndrome poliglandular autoimune tipo II, Revista Portuguesa de Endocrinologia, Diabetes e Metabolismo, 2012, 7, 2, 13

    CrossRef

  15. 15
    Haiying Yu, Zhonghua Sun, Junsheng Cui, Guohua Song, Fuqing Wang, Fenglan Gao, Xiaobin Liu, Jinsong Ni, Xinrui Wang, Epidermal Growth Factor and Gastrin on PDX1 Expression in Experimental Type 1 Diabetic Rats, The American Journal of the Medical Sciences, 2012, 343, 2, 141

    CrossRef

  16. 16
    Lirong Li, Weiqiong Gu, Dalong Zhu, Novel therapy for Type 1 diabetes - autologous hematopoietic stem cell transplantation, Journal of Diabetes, 2012, no

    CrossRef

  17. 17
    Stella Korsgren, Ylva Molin, Kaija Salmela, Torbjörn Lundgren, Åsa Melhus, Olle Korsgren, On the Etiology of Type 1 Diabetes, The American Journal of Pathology, 2012, 181, 5, 1735

    CrossRef

  18. 18
    Robert W. Ledeen, Gusheng Wu, David Bleich, Zi-Hua Lu, Hans-Joachim Gabius, Galectins and Disease Implications for Targeted Therapeutics, 2012,

    CrossRef

  19. 19
    Bart O Roep, Mark Peakman, Diabetogenic T lymphocytes in human Type 1 diabetes, Current Opinion in Immunology, 2011, 23, 6, 746

    CrossRef

  20. 20
    Kai He, Xuegang Li, Xin Chen, Xiaoli Ye, Jing Huang, Yanan Jin, Panpan Li, Yafei Deng, Qing Jin, Qing Shi, Hejing Shu, Evaluation of antidiabetic potential of selected traditional Chinese medicines in STZ-induced diabetic mice, Journal of Ethnopharmacology, 2011, 137, 3, 1135

    CrossRef

  21. 21
    Mark C. Johnson, Bo Wang, Roland Tisch, Genetic vaccination for re-establishing T-cell tolerance in type 1 diabetes, Human Vaccines, 2011, 7, 1, 27

    CrossRef

  22. 22
    Pieter Gillard, Chantal Mathieu, Immune and cell therapy in type 1 diabetes: too little too late?, Expert Opinion on Biological Therapy, 2011, 11, 5, 609

    CrossRef

  23. 23
    Frank Waldron-Lynch, Kevan C. Herold, Immunomodulatory therapy to preserve pancreatic β-cell function in type 1 diabetes, Nature Reviews Drug Discovery, 2011, 10, 6, 439

    CrossRef

  24. 24
    K. T. Coppieters, N. Amirian, M. G. von Herrath, Incidental CD8 T cell reactivity against caspase-cleaved apoptotic self-antigens from ubiquitously expressed proteins in islets from prediabetic human leucocyte antigen-A2 transgenic non-obese diabetic mice, Clinical & Experimental Immunology, 2011, 165, 2
  25. 25
    K. Vehik, D. Cuthbertson, H. Ruhlig, D. A. Schatz, M. Peakman, J. P. Krischer, Long-Term Outcome of Individuals Treated With Oral Insulin: Diabetes Prevention Trial-Type 1 (DPT-1) oral insulin trial, Diabetes Care, 2011, 34, 7, 1585

    CrossRef

  26. 26
    Bart O Roep, New hope for immune intervention therapy in type 1 diabetes, The Lancet, 2011, 378, 9789, 376

    CrossRef

  27. 27
    Ben Sprangers, Bart Van der Schueren, Pieter Gillard, Chantal Mathieu, Otelixizumab in the treatment of Type 1 diabetes mellitus, Immunotherapy, 2011, 3, 11, 1303

    CrossRef

  28. 28
    Alberto Pugliese, Helena K Reijonen, Jerry Nepom, George W Burke, Recurrence of autoimmunity in pancreas transplant patients: research update, Diabetes Management, 2011, 1, 2, 229

    CrossRef

  29. 29
    Júlio C. Voltarelli, Carlos E.B. Couri, Maria C. Oliveira, Daniela A. Moraes, Ana B.P.L. Stracieri, Fabiano Pieroni, George M.N. Barros, Kelen C.R. Malmegrim, Belinda P. Simões, Angela M.O. Leal, Milton C. Foss, Stem cell therapy for diabetes mellitus, Kidney International Supplements, 2011, 1, 3, 94

    CrossRef

  30. 30
    Peter Achenbach, Liang-Hao Guo, Claudia Gick, Kerstin Adler, Stephanie Krause, Ezio Bonifacio, Peter G. Colman, Anette-G. Ziegler, A simplified method to assess affinity of insulin autoantibodies, Clinical Immunology, 2010, 137, 3, 415

    CrossRef

  31. 31
    Rodolfo José Chaparro, Teresa P DiLorenzo, An update on the use of NOD mice to study autoimmune (Type 1) diabetes, Expert Review of Clinical Immunology, 2010, 6, 6, 939

    CrossRef

  32. 32
    M. Peakman, M. von Herrath, Antigen-Specific Immunotherapy for Type 1 Diabetes: Maximizing the Potential, Diabetes, 2010, 59, 9, 2087

    CrossRef

  33. 33
    Jun Liu, Ting He, Qian Lu, Jing Shang, Hongbin Sun, Luyong Zhang, Asiatic acid preserves beta cell mass and mitigates hyperglycemia in streptozocin-induced diabetic rats, Diabetes/Metabolism Research and Reviews, 2010, 26, 6
  34. 34
    Aaron W. Michels, Peter A. Gottlieb, Autoimmune polyglandular syndromes, Nature Reviews Endocrinology, 2010, 6, 5, 270

    CrossRef

  35. You have free access to this content35
    J. B. Matthews, T. P. Staeva, P. L. Bernstein, M. Peakman, M. Von Herrath, Developing combination immunotherapies for type 1 diabetes: recommendations from the ITN–JDRF Type 1 Diabetes Combination Therapy Assessment Group, Clinical & Experimental Immunology, 2010, 160, 2
  36. 36
    Tamara Cvjetićanin, Djordje Miljković, Ivana Stojanović, Dragana Dekanski, Stanislava Stošić-Grujičić, Dried leaf extract of Olea europaea ameliorates islet-directed autoimmunity in mice, British Journal of Nutrition, 2010, 103, 10, 1413

    CrossRef

  37. 37
    Michael J. Haller, Mark A. Atkinson, Desmond A. Schatz, Efforts to Prevent and Halt Autoimmune Beta Cell Destruction, Endocrinology and Metabolism Clinics of North America, 2010, 39, 3, 527

    CrossRef

  38. 38
    Aaron W. Michels, George S. Eisenbarth, Immunologic endocrine disorders, Journal of Allergy and Clinical Immunology, 2010, 125, 2, S226

    CrossRef

  39. 39
    T. I. M. Tree, J. Lawson, H. Edwards, A. Skowera, S. Arif, B. O. Roep, M. Peakman, Naturally Arising Human CD4 T-Cells That Recognize Islet Autoantigens and Secrete Interleukin-10 Regulate Proinflammatory T-Cell Responses via Linked Suppression, Diabetes, 2010, 59, 6, 1451

    CrossRef

  40. 40
    M. Walter, T. Kaupper, K. Adler, J. Foersch, E. Bonifacio, A.-G. Ziegler, No Effect of the 1 ,25-Dihydroxyvitamin D3 on  -Cell Residual Function and Insulin Requirement in Adults With New-Onset Type 1 Diabetes, Diabetes Care, 2010, 33, 7, 1443

    CrossRef

  41. 41
    F. Vendrame, A. Pileggi, E. Laughlin, G. Allende, A. Martin-Pagola, R. D. Molano, S. Diamantopoulos, N. Standifer, K. Geubtner, B. A. Falk, H. Ichii, H. Takahashi, I. Snowhite, Z. Chen, A. Mendez, L. Chen, J. Sageshima, P. Ruiz, G. Ciancio, C. Ricordi, H. Reijonen, G. T. Nepom, G. W. Burke, A. Pugliese, Recurrence of Type 1 Diabetes After Simultaneous Pancreas-Kidney Transplantation, Despite Immunosuppression, Is Associated With Autoantibodies and Pathogenic Autoreactive CD4 T-Cells, Diabetes, 2010, 59, 4, 947

    CrossRef

  42. 42
    G. Fousteri, A. Dave, A. Bot, T. Juntti, S. Omid, M. von Herrath, Subcutaneous insulin B:9-23/IFA immunisation induces Tregs that control late-stage prediabetes in NOD mice through IL-10 and IFNγ, Diabetologia, 2010, 53, 9, 1958

    CrossRef

  43. 43
    Bart O. Roep, Mark Peakman, Surrogate end points in the design of immunotherapy trials: emerging lessons from type 1 diabetes, Nature Reviews Immunology, 2010, 10, 2, 145

    CrossRef

  44. 44
    G. Fousteri, J. R. Chan, Y. Zheng, C. Whiting, A. Dave, D. Bresson, M. Croft, M. von Herrath, Virtual Optimization of Nasal Insulin Therapy Predicts Immunization Frequency to Be Crucial for Diabetes Protection, Diabetes, 2010, 59, 12, 3148

    CrossRef

  45. 45
    M. Reimann, E. Bonifacio, M. Solimena, P.E.H. Schwarz, B. Ludwig, M. Hanefeld, S.R. Bornstein, An update on preventive and regenerative therapies in diabetes mellitus, Pharmacology & Therapeutics, 2009, 121, 3, 317

    CrossRef

  46. 46
    J. Tian, D. L. Kaufman, Antigen-Based Therapy for the Treatment of Type 1 Diabetes, Diabetes, 2009, 58, 9, 1939

    CrossRef

  47. 47
    Michael A. Zimmerman, Sonia C. Flores, Autoimmune-Mediated Oxidative Stress and Endothelial Dysfunction: Implications of Accelerated Vascular Injury in Type I Diabetes, Journal of Surgical Research, 2009, 155, 1, 173

    CrossRef

  48. 48
    Nathan E. Standifer, Emily A. Burwell, Vivian H. Gersuk, Carla J. Greenbaum, Gerald T. Nepom, Changes in autoreactive T cell avidity during type 1 diabetes development, Clinical Immunology, 2009, 132, 3, 312

    CrossRef

  49. 49
    M. Rewers, P. Gottlieb, Immunotherapy for the Prevention and Treatment of Type 1 Diabetes: Human trials and a look into the future, Diabetes Care, 2009, 32, 10, 1769

    CrossRef

  50. 50
    D. Bresson, M. von Herrath, Immunotherapy for the Prevention and Treatment of Type 1 Diabetes: Optimizing the path from bench to bedside, Diabetes Care, 2009, 32, 10, 1753

    CrossRef

  51. 51
    E. Vandemeulebroucke, F.K. Gorus, K. Decochez, I. Weets, B. Keymeulen, C. De Block, J. Tits, D.G. Pipeleers, C. Mathieu, Insulin treatment in IA-2A-positive relatives of type 1 diabetic patients, Diabetes & Metabolism, 2009, 35, 4, 319

    CrossRef

  52. 52
    J. S. Allen, K. Pang, A. Skowera, R. Ellis, C. Rackham, B. Lozanoska-Ochser, T. Tree, R. D. G. Leslie, J. M. Tremble, C. M. Dayan, M. Peakman, Plasmacytoid Dendritic Cells Are Proportionally Expanded at Diagnosis of Type 1 Diabetes and Enhance Islet Autoantigen Presentation to T-Cells Through Immune Complex Capture, Diabetes, 2009, 58, 1, 138

    CrossRef

  53. 53
    J. Spencer, M. Peakman, Post-mortem analysis of islet pathology in type 1 diabetes illuminates the life and death of the β cell, Clinical & Experimental Immunology, 2009, 155, 2
  54. 54
    S. L. Thrower, L. James, W. Hall, K. M. Green, S. Arif, J. S. Allen, C. Van-Krinks, B. Lozanoska-Ochser, L. Marquesini, S. Brown, F. S. Wong, C. M. Dayan, M. Peakman, Proinsulin peptide immunotherapy in type 1 diabetes: report of a first-in-man Phase I safety study, Clinical & Experimental Immunology, 2009, 155, 2
  55. 55
    J. A. Todd, Stem cells and a cure for type 1 diabetes?, Proceedings of the National Academy of Sciences, 2009, 106, 37, 15523

    CrossRef

  56. 56
    K. C. Herold, B. Brooks-Worrell, J. Palmer, H. M. Dosch, M. Peakman, P. Gottlieb, H. Reijonen, S. Arif, L. M. Spain, C. Thompson, J. M. Lachin, Validity and Reproducibility of Measurement of Islet Autoreactivity by T-Cell Assays in Subjects With Early Type 1 Diabetes, Diabetes, 2009, 58, 11, 2588

    CrossRef

  57. 57
    Júlio C. Voltarelli, Carlos E.B. Couri, Ana B.P.L. Stracieri, Maria C. Oliveira, Daniela A. Moraes, Fabiano Pieroni, George M.N. Barros, Maria Isabel A. Madeira, Kelen C.R. Malmegrim, Maria C. Foss-Freitas, Belinda P. Simões, Milton C. Foss, Elizabeth Squiers, Richard K. Burt, Autologous Hematopoietic Stem Cell Transplantation for Type 1 Diabetes, Annals of the New York Academy of Sciences, 2008, 1150, 1
  58. 58
    L.-J. Yang, Big Mac Attack: Does It Play a Direct Role for Monocytes/Macrophages in Type 1 Diabetes?, Diabetes, 2008, 57, 11, 2922

    CrossRef

  59. 59
    Ania Skowera, Richard J. Ellis, Ruben Varela-Calviño, Sefina Arif, Guo Cai Huang, Cassie Van-Krinks, Anna Zaremba, Chloe Rackham, Jennifer S. Allen, Timothy I.M. Tree, Min Zhao, Colin M. Dayan, Andrew K. Sewell, Wendy Unger, Jan W. Drijfhout, Ferry Ossendorp, Bart O. Roep, Mark Peakman, CTLs are targeted to kill β cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope, Journal of Clinical Investigation, 2008,

    CrossRef

  60. 60
    P. Achenbach, L. Pan, A.-G. Ziegler, Frühdiagnostik bei Typ-1-Diabetes, Der Diabetologe, 2008, 4, 1, 47

    CrossRef

  61. 61
    Y. Lu, M. Parker, A. Pileggi, B. Zhang, Y.-K. Choi, R. D. Molano, C. Wasserfall, C. Ricordi, L. Inverardi, M. Brantly, D. Schatz, M. Atkinson, S. Song, Human alpha 1-antitrypsin therapy induces fatal anaphylaxis in non-obese diabetic mice, Clinical & Experimental Immunology, 2008, 154, 1
  62. 62
    V. A. L. Huurman, P. E. Van Der Meide, G. Duinkerken, S. Willemen, I. R. Cohen, D. Elias, B. O. Roep, Immunological efficacy of heat shock protein 60 peptide DiaPep277TM therapy in clinical type I diabetes, Clinical & Experimental Immunology, 2008, 152, 3
  63. 63
    Gunjan Y. Gandhi, M. Hassan Murad, David N. Flynn, Mohamed B. Elamin, Patricia J. Erwin, Victor M. Montori, Yogish C. Kudva, Immunotherapeutic agents in type 1 diabetes: a systematic review and meta-analysis of randomized trials, Clinical Endocrinology, 2008, 69, 2
  64. 64
    J. M. Lawson, J. Tremble, C. Dayan, H. Beyan, R. D. G. Leslie, M. Peakman, T. I. M. Tree, Increased resistance to CD4+CD25hi regulatory T cell-mediated suppression in patients with type 1 diabetes, Clinical & Experimental Immunology, 2008, 154, 3
  65. 65
    Bo Wang, Roland Tisch, Parameters influencing antigen-specific immunotherapy for type 1 diabetes, Immunologic Research, 2008, 41, 3, 175

    CrossRef

  66. 66
    Bo Wang, Roland Tisch, Parameters influencing antigen-specific immunotherapy for Type 1 diabetes, Immunologic Research, 2008, 42, 1-3, 246

    CrossRef

  67. 67
    David B Dunger, John A Todd, Prevention of type 1 diabetes: what next?, The Lancet, 2008, 372, 9651, 1710

    CrossRef

  68. 68
    Marianne M. Martinic, Matthias G. Von Herrath, Real-time imaging of the pancreas during development of diabetes, Immunological Reviews, 2008, 221, 1
  69. 69
    Rémi J. Creusot, Shahriar S. Yaghoubi, Keiichi Kodama, Demi N. Dang, Vu H. Dang, Karine Breckpot, Kris Thielemans, Sanjiv S. Gambhir, C. Garrison Fathman, Tissue-targeted therapy of autoimmune diabetes using dendritic cells transduced to express IL-4 in NOD mice, Clinical Immunology, 2008, 127, 2, 176

    CrossRef

  70. 70
    Jennifer Bollyky, Srinath Sanda, Carla J. Greenbaum, Type 1 diabetes mellitus: primary, secondary, and tertiary prevention, Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine, 2008, 75, 4
  71. 71
    Carlos Eduardo Barra Couri, Maria Cristina Foss-Freitas, Milton César Foss, Júlio César Voltarelli, β-cell regeneration to treat Type 1 diabetes mellitus, Expert Review of Endocrinology & Metabolism, 2008, 3, 1, 51

    CrossRef

  72. 72
    Craig Taplin, Jennifer Barker, Epidemiology of Pediatric and Adolescent Diabetes, 2008,

    CrossRef

  73. 73
    Jennifer M. Barker, Endocrine Manifestations of Systemic Autoimmune Diseases, 2008,

    CrossRef

  74. 74
    Stephen D. Miller, Danielle M. Turley, Joseph R. Podojil, Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease, Nature Reviews Immunology, 2007, 7, 9, 665

    CrossRef

  75. 75
    Corrigenda, Clinical & Experimental Immunology, 2007, 149, 1
  76. 76
    I. Truyen, J. De Grijse, I. Weets, L. Kaufman, L. Pipeleers, N. Nanos, K. Decochez, R. Hilbrands, J-M. Kaufman, B. Keymeulen, C. Mathieu, L. Van Gaal, D. G. Pipeleers, F. K. Gorus, Identification of prediabetes in first-degree relatives at intermediate risk of type I diabetes, Clinical & Experimental Immunology, 2007, 149, 2
  77. 77
    Jennifer M Barker, George S Eisenbarth, Primary prevention of type 1A diabetes: are we there yet?, Pediatric Diabetes, 2007, 8, 3
  78. 78
    P. Van De Linde, P. J. M. vd Boog, O. M. H. Tysma, J. F. Elliott, D. L. Roelen, F. H. J. Claas, J. W. De Fijter, B. O. Roep, Selective unresponsiveness to beta cell autoantigens after induction immunosuppression in pancreas transplantation with anti-interleukin-2 receptor antibody versus anti-thymocyte globulin, Clinical & Experimental Immunology, 2007, 149, 1
  79. 79
    Michael J Haller, Peter A Gottlieb, Desmond A Schatz, Type 1 diabetes intervention trials 2007: where are we and where are we going?, Current Opinion in Endocrinology, Diabetes and Obesity, 2007, 14, 4, 283

    CrossRef

  80. 80
    F. Klauschen, B. R. Angermann, M. Meier-Schellersheim, Understanding diseases by mouse click: the promise and potential of computational approaches in Systems Biology, Clinical & Experimental Immunology, 2007, 149, 3
  81. 81
    Helena Elding Larsson, Ahmed J. Delli, Sten-A. Ivarsson, Åke Lernmark, Future Drug Treatment for Type 1 Diabetes,